SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

23 May 2025 Evaluate
A fair growth of 23.72% in the revenue at Rs. 2725.96 millions was reported in the March 2025 quarter as compared to Rs. 2203.30 millions during year-ago period.The Total Profit for the quarter ended March 2025 of Rs. 156.19 millions grew from Rs.-440.73 millions Operating profit Margin for the quarter ended March 2025 improved to 422.07% as compared to -200.95% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2725.96 2203.30 23.72 8864.91 7732.62 14.64 8864.91 7732.62 14.64
Other Income 89.37 55.52 60.97 206.15 188.83 9.17 206.15 188.83 9.17
PBIDT 422.07 -200.95 -310.04 912.18 460.13 98.24 912.18 460.13 98.24
Interest 174.39 138.76 25.68 661.19 543.26 21.71 661.19 543.26 21.71
PBDT 250.32 -358.99 -169.73 -709.03 -102.41 592.34 -709.03 -102.41 592.34
Depreciation 131.35 127.83 2.75 525.27 493.90 6.35 525.27 493.90 6.35
PBT 118.97 -486.82 -124.44 -1234.30 -596.31 106.99 -1234.30 -596.31 106.99
TAX -37.22 -46.09 -19.24 -471.20 -82.43 471.64 -471.20 -82.43 471.64
Deferred Tax -37.22 -39.81 -6.51 -487.80 -82.43 491.77 -487.80 -82.43 491.77
PAT 156.19 -440.73 -135.44 -763.10 -513.88 48.50 -763.10 -513.88 48.50
Equity 187.92 167.47 12.21 187.92 167.47 12.21 187.92 167.47 12.21
PBIDTM(%) 15.48 -9.12 -269.77 10.29 5.95 72.92 10.29 5.95 72.92

Camlin Fine Sciences Share Price

130.25 -0.40 (-0.31%)
06-May-2026 12:53 View Price Chart
Peers
Company Name CMP
BASF India 3668.25
Tata Chemicals 807.15
SRF 2724.80
Pidilite Inds. 1412.80
Deepak Nitrite 1796.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×